| Authors: |
Forst DA; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA dforst@partners.org., Rhee JY; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Mesa MM; Cancer Outcomes Research and Education Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Podgurski AF; Cancer Outcomes Research and Education Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Strander SM; Cancer Outcomes Research and Education Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Datta S; Cancer Outcomes Research and Education Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Kaslow-Zieve E; Cancer Outcomes Research and Education Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Horick NK; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Greer JA; Department of Psychiatry, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., El-Jawahri A; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Sannes TS; Adult Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Temel JS; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Jacobs J; Department of Psychiatry, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA. |